Posts

Showing posts from October, 2024

[20th October 2024] Interesting Things I Learnt This Week

Image
1. Why Founders Need to Focus More on Sales and Marketing - Harvard Business School senior lecturer Mark Roberge argues that every aspect of being an early-stage founder involves sales. But many founders lack an understanding of how to incorporates sales into their ventures. This talks about how to hire for early sales roles, design compensation, and lay a strong foundation for a growing sales team. Hiring the right salesperson is crucial, as they should be skilled in both product knowledge and customer interaction. Scaling sales requires a strategic approach, considering factors like product-market fit and customer retention. The sales compensation plan can be a powerful tool for aligning sales behavior with business goals. While AI is making strides in automating certain sales tasks, the human element of building relationships and understanding customer needs remains indispensable. My Take : IMHO a startup is like an elephant from the story of blind men and an elephant . There are d

[13th October 2024] Interesting Things I Learnt This Week

Image
1. ROS : ROS (Robot Operating System) is a versatile open-source framework that simplifies robot development. It provides a modular architecture, robust communication mechanisms, and a vast ecosystem of tools and libraries. This comprehensive platform empowers developers to create efficient and innovative robotic systems, from hardware abstraction to high-level behavior control. ROS's flexibility and adaptability make it suitable for a wide range of robot applications, while its active community fosters collaboration and knowledge sharing. My Take:  I recently discovered ROS, which has been around since 2007. It's remarkable that such a powerful tool has existed for so long. Over the years, ROS has evolved into a comprehensive platform, offering a vast array of algorithms to simplify robot development. The ability to run ROS on Raspberry Pis further enhances its capabilities, making it a versatile choice for a wide range of robotic projects. 2. Should we be worried about vega

RIP Ratan Tata

Image
My career began with Tata Elxsi, right after completing my BE in Computer Science, marking a significant milestone in my career. It was my first taste of the corporate world, and while not everything was perfect, the experience I gained there has been invaluable. I'm particularly grateful to JRD Tata and Ratan Tata for his vision in establishing Tata Elxsi as a pure electronics and software technology services company. In a landscape dominated by consulting firms, Tata Elxsi's focus on technology and product innovation was refreshing. The company's history in India is a testament to its commitment to technological advancement. Founded in 1989 as a joint venture between the Tata Group and France's Thomson-CSF, Tata Elxsi has played a pioneering role in India's IT industry. Though what it started with and how is diversified into a variety of different fields is an amazing story by itself. He was the true visionaries who managed to build not just one but a spectrum of

[6th October 2024] Interesting Things I Learnt This Week

Image
 1. Stem cells reverse woman’s diabetes - Scientists have achieved a breakthrough in treating type 1 diabetes by using reprogrammed stem cells. A woman was successfully treated by receiving a transplant of these cells into her abdominal muscles. Following the transplant, she was able to maintain stable blood sugar levels without insulin for over a year. This is the first time such an approach has shown to be effective in reversing type 1 diabetes. While this is a promising development, more research is needed to confirm its long-term safety and efficacy in a larger group of people. My Take : This is a groundbreaking discovery. My father, along with millions of others, suffers from diabetes. Unfortunately, due to genetics, I'm likely to join them soon. However, this news offers hope not only for me but also for countless individuals who endure daily injections. I sincerely hope that the cost of this treatment remains affordable. Perhaps the government could intervene to ensure acce